Building on the 100,000 Genomes Project and existing genetic services, NHS England announced in October 2018 that over the next 18 months work to mobilise the NHS Genomic Medicine Service (GMS) would get underway. The aims of the GMS are to:
- Provide consistent and equitable care for the country’s 55 million population;
- Operate to common national standards, specifications and protocols;
- Deliver to a single national genomic testing directory – covering use of all technologies from single gene to whole genome sequencing initially for rare disease and cancer;
- Give all patients the opportunity to participate in research, for individual benefit and to inform future care; and
- Build a national genomic knowledge base to provide real world data to inform.
Through the GMS, NHS England will be exploring how to ensure that the funding flows for cancer support equity of access to testing across the country.